Clinical studies are needed to identify cancer populations that may benefit from TRPV2 as a molecular biomarker and perhaps will open new prospectives to explore TRPV2 as a novel therapeutic target in cancer and metastasis. This evidence concerns the gene TRPV2 and cancer.